NO TUITION FEE for Pre-Clinical(MD/MS)/Para Clinical(MD) courses except for MD Pathology course for the A.Y.2024-25                 Hall tickets to be issued for MBBS Phase-I and Phase -II December 2024 examination.                

Awards & Achievements

Awards & Achievements

Shashidhar V Karpurmath , Professor & HOD
Awards and Laurels
  • Shashidhar V Karpurmath won the 1st prize ORAL PRESENTATION in the HAEMATO-ONCOLOGY section in REAL WORLD EVIDENCE NATIONAL CONFERENCE 2019.
  • Cleared ESMO certification exam in 2019.
  • Awarded as the BEST PHYSICIAN of 2019 in RESEARCH CATEGORY at Vydehi.
  • Is currently, the ORGANISING SECRETARY of COLLABORATIVE MEDICAL ONCOLOGY GROUP (CMOG).
  • Got approval for conducting ICMR project as guide to MBBS student in the year 2020 titled “To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients”.
International Conferences
  1. ESMO update for practicing oncologists 2018, Lugano, Switzerland.
  2. Attended the per mentorship programme in Frankfurt Germany at UKGM (GIESSEN university) in SEPTEMBER 2016.
National Conferences
  1. Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.
  2. Attended and completed ‘STRUCTURED OPERATIONAL RESEARCH TRAINING INITIATIVE’ course conducted by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO.
  3. Was invited as a speaker at APEX PROFESSIONAL UNIVERSITY on the occasion of WORLD CANCER DAY 2021- delivered a talk titled ‘IS DIAGNOSIS OF CANCER ALWAYS A DEATH SENTENCE’.
  4. Was appointed as subject expert as part of Local Inspection Committee from RGUHS regarding inspections in KIDWAI     Memorial Institute Of Oncology, March 2021.
  5. Was appointed as subject expert as part of Expert Committee regarding promotion of the faculty in medical Oncology at KIDWAI 2019, M.S.Ramiah 2019, Manipal Academy of Higher Education 2019.
Presentations in the last 5 years
  1. Invited as a guest speaker in ‘SPOTLIGHT ON PRECISION ONCOLOGY CONFERENCE ‘held at Chennai on 25thmay 2024.
  2. Attended module 3 of SORT IT (Structured operational research training initiative) held at Cachar cancer centre, Silchar Assam in May 7-12, 2024 an initiative of ICMR –NIE.
  3. Invited as a speaker in the 2ndInternational global cancer consortium conference held at KMC Manipal on Jan 7th
  4. Attended as an invited faculty for the 8thedition of year in review breast cancer conference at Mumbai 22nd Jan 2023.
  5. Attended the CMOG ( Collaborative Medical oncology Group ) meeting at Bengaluru on 13/03/2022
  6. Invited as Guest Speaker in the CME conducted by G V N Cancer Centre and IMA Trichy at Trichy on 05/06/2022 and delivered his lecture on the topic – Oncology-Physician Rapport in Shared care Model
  7. Invited as faculty and participated as a panelist in the “Cancer Pain Management “CME held on 15/10/2022 at Vydehi Institute of Medical Sciences and Research Centre.
  8. Invited as faculty and participated as guest speaker and gave a talk in a national webinar on “Recent advances in Lung Cancer Management “ in the CME – Recent Advances in Pulmonology on 06/12/2022, conducted by the Department of Pulmonology,  Vydehi Institute Of Medical Sciences and Research Centre .
  9. Halving time of BCR-Abl1 levels –Is it a better Bet than day 90 Bcr-Abl1 in chronic phase Chronic Myeloid leukemia patients .Presented in Real world Evidence – National conference conducted at Chennai in august 2019.
  10. Presented the Data on GIST in conference conducted by collaborative Medical Oncology Group at Vijayawada in 2018.
  11. Presented –Should different types of Breast Cancer be staged differently in National conference Breast con 2018, held at Kasturba Medical College Manipal.
  12. Presented the Hospital data at NCDIR meeting held at Bengaluru and also took part in the meeting for consensus on POCSS form for Hematological malignancies for Hospital Based cancer Registries in 2018
  13. Presented in Indian Cancer Congress 2017 held in Bengaluru in a Genitor-Urinary session.
  14. Presented in Molecular Tumor Board of CML – International Conference held in Chennai in 2016.
  15. Presented a poster in ISMPO-ISO conference held in Mumbai in 2015.
  16. Attended the CMOG (Collaborative Medical oncology Group) meeting at Bengaluru on 13/03/2022
  17. Attended the “Cancer Pain Management “CME held on 15/10/2022 at Vydehi Institute of Medical Sciences and Research Centre.
  18. Attended the national webinar on “Recent advances in Lung Cancer Management “ in the CME – Recent Advances in Pulmonology on 06/12/2022,conducted by the Department of Pulmonology, Vydehi Institute Of Medical Sciences and Research Centre
  19. Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.
Recognized by University for additional roles & responsibilities
  1. Appointed as External Member of Board of Studies for Medical Oncology at Kasturba Medical College, Manipal Academy of Higher Education (MAHE) from 2020 to 2024
  2. Appointed as part of Local inspection committee as subject expert for Inspection at Kidwai cancer centre as per the appointment order RGU/AC2/AFF/MED/LIC/2020-21 dated 26/02/2021
  3. Appointed to monitor the research activities pertaining to 2 Medical Oncology  Research projects for the year 2018-19 as per the appointment order RGU/ADV-RES/BR/001/2018-19 dated 15/09/2020
  4. Appointed as External examiner for the DM Medical Oncology practical exams at Amrita Vishwa Vidyapeetha, Kochi; Sri Aurobindo Institute of Medical College, Indore;  Madras Medical College, Chennai; Madurai Medical College, Madurai; Kasturba Medical College, Manipal from 2017 to 2024
  5. Appointed as Internal examiner for the DM Medical Oncology practical exams at Kidwai memorial Institute of Oncology in the year 2017 and 2018
  6. Appointed as Internal examiner for the DM Medical oncology practical Examinations at Vydehi Institute of medical Sciences and Research Centre in the years 2016, 2017, 2019, 2021 and  2023
  7. Has been appointed as part of Committee as Subject expert in Medical Oncology  for the selection / promotion for the faculty of Medical Oncology at Kidwai memorial Institute of oncology, Kasturba Medical College and at MS Ramaiah Medical College from 2019 to 2024
Projects undertaken in the last 5 years
  1. To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients
  2. As a guide to MBBS student ,Ongoing project , research proposal accepted by ICMR under STS (Short term Studentship) for the year 2020
  3. Multi-Centre study was undertaken and completed as part of SORT IT (Structured Operational Research Training Initiative) by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO in 2018-19 – Halving Time of Bcr-Abl1 compared to conventional Day 90 Bcr-Abl1 in chronic myeloid leukemia patients in chronic phase.
  4. Worked as Co-investigator for Neo-adjuvant chemo-radiation therapy in T4 resectable oral cavity cancer project undertaken in the Department of oncology at Vydehi Institute of Medical Sciences and Research Centre  2017-2019
  5. As a guide to DM Medical oncology Post graduate for the project -Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population in 2017-2018
  6. As a coinvestigator to the project -Novel single day premedication regimen for prevention of paclitaxel induced hypersensitivity reaction 2017
  7. Ongoing project as PI – One of the participating centres for the phase III, multi centre RCT –NAGA (Neoadjuvant vs adjuvant chemotherapy in gastric adeno ca).
  8. Manjunath Nandennavar , Professor
International Conferences
  • Attended ICC conference in Delhi, 2013 and Bangalore, 2019 as a delegate.
Invited as faculty / speaker – National conferences
  1. Attended the CMOG ( Collaborative Medical oncology Group ) meeting at Bengaluru on 13/03/2022
  2. Attended the “Cancer Pain Management “CME held on 15/10/2022 at Vydehi Institute of Medical Sciences and Research Centre.
  3. Attended the national webinar on “Recent advances in Lung Cancer Management “in the CME – Recent Advances in Pulmonology on 06/12/2022, conducted by the Department of Pulmonology, Vydehi Institute of Medical Sciences and Research Centre.
  4. Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.
  5. .Presented ‘Comparison of outcomes of 5FU vs. Taxane based chemotherapy regimens in metastatic stomach cancer: results from a tertiary cancer center in south India’ in Real world Evidence – National conference conducted at Chennai in august 2019.
Projects undertaken in the last 5 years
  1. As a guide to MBBS student, Ongoing project, research proposal accepted by ICMR under STS (Short term Studentship) for the year 2023.
  2. Multi-center study was undertaken and completed as part of SORT IT (Structured Operational Research Training Initiative) by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO in 2018-19 –Comparison of outcomes of 5FU vs. Taxane based chemotherapy regimens in metastatic stomach cancer: results from a tertiary cancer center in south India.
  3. As a PI in Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas.
  4. As a CO PI in Phase-I studies- A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicenter, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies
  5. As a CO PI in NAGA trial: A phase III, multi centre RCT –Neoadjuvant vs adjuvant chemotherapy in gastric Adeno carcinoma. Principal investigators
Recognized by University for additional roles & responsibilities
  1. Appointed as external examiner for the DNB Medical Oncology practical exams at Madurai Meenakshi mission institute in February 2024.
  2. Appointed as Internal examiner for the DM Medical oncology practical Examinations at Vydehi Institute of medical Sciences and Research Centre in the years 2019,2020,2021,2022 and 2023.
  3. Has been appointed as part of Committee as Subject expert in Medical Oncology for the selection / promotion for the faculty of Medical Oncology at MS Ramaiah medical college in 2024.
  4. Veerendra Angadi , Assistant Professor  
National Conferences
  1. Attended ISMPO ISO conference in Nov 2015. Presented POSTER presentation on Progressive Multifocal Leukoencephalopathy-Rare demyelinating disorder in a patient with SLL.
  2. VICON 2014, Vydehi Institute of Medical sciences and Research centre, Bangalore.
  3. Pediatric oncology CME programme at Shankara cancer Hospital, Bangalore.
  4. CME on Gastric and OG Junction cancers: Update.
Clinical Research Experience
  1. A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicentre, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies. Co-Investigator.
  2. A phase IIb/III, Randomized, Double-blind, Placebo-Controlled, Multicenter, Study of CA-170 in combination with Chemotherapy in patients with Stage IV Non-Squamous Non-Small Cell lung Cancer. Co-Investigator.
  3. A Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas. Co-Investigator.
  4. An open label, Multi-Centre, Randomised, Two-Treatment, Multi dose, parallel, Comparative Bioavailability Study of Bertezomib Injection 3.5mg/0.2ml and VECADE 3.5mg powder for solution for injection at a dose of .3mg/m2 in Multiple Myeloma Patients. Co-Investigator.
  5. A multi-centre, Double-Blind, randomized parallel Group, Active controlled, Two Part, Phase-III, Global Study to Evaluate the Pharmacokinetics, Effiacy,and Safety of BP 02(Trastuzumab) in Comparison with Herceptin- EU in patients with Her2-positive Early Breast Cancer and Metastatic Breast Cancer. Co-Investigator.
  6. Prospective , multi-centre, randomized, double-blind, two-arm, parallel group, active control, comparative clinical study to evaluate efficacy and safety of R-TPR_045/Xgeva for prevention of skeletal related events in patients with bone metastases from solid tumors. Co-Investigator.
RGUHS UNIVERSITY RANK HOLDERS IN DM MEDICAL ONCOLOGY
  • Dr. Vishnu Priyanka J- 5th Rank in 2023
  • Dr. Swaroopa Chundru- 3rd Rank in 2021
  • Dr. Mehlam Kausar- 4th Rank in 2020
  • Dr. Sai Vivek V- 2nd Rank in 2019

Academic laurels and Achievements of DM Medical Oncology Residents

Sl. No SS PG Name Event /Conference Prize /Presentation Topic Date / Month &Year
I Dr. Subha Supriya
  1 ISMPO / ISOCON 2022 Oral presentation Rare case report on Synovial Sarcoma in Infancy.

October

2022
  2 GI CON Oral presentation  MANEC May 2023,
  3 Nuclear Medicine Updates CME Nuclear Medicine Updates DEC 23
  4 Best of ASCO Oral presentation   MARCH 2024
  5 AMOI 2ND PRIZE AMOI Crossword MARCH 2024
II Dr. Shruthi Swamy
  1 AMOI 1ST PRIZE Oncology Premier League Quiz  June 2022
  2 AMOI 1ST PRIZE Debate on Can Triple therapy be made SOC in MCSPC

September

2022
  3 ISMPO / ISOCON 2022 Oral presentation Institutional experience of PCNSL at a tertiary care centre

October

2022
  4 ISMPO / ISOCON 2022 Oral presentation Thiotepa based auto MT in PCNSL October 2022
  5 ISMPO / ISOCON 2022 Oral presentation  Review article on Triplet Therapy in MCSPC October 2022
  6 AMOI 1ST PRIZE Grand Quiz(Oncology Premier League Finals) November 2022
  7 AMOI 3rd prize Oncology Premier League Quiz August 2023
  8 Best of ASCO Oral presentation CONTACT study phase III trial- Atezolizumab+ Cabozantinib in  MRCC MARCH 2024
III Dr. Praneetha
  1 AMOI 1ST PRIZE AMOI Quiz AUG 2023
  2 AMOI 2ND PRIZE AMOI Crossword MARCH 2024
  3 RWE Oral Presentation Is FLOT really superior?? A Real world experience from a tertiary cancer centre in India in locally advanced gastric cancer April,2023
  4 ISMPO- ISOCON Oral Presentation Chronic Myeloid Leukemia in a 3year old child- a rare case report Oct,2022
IV Dr. Nitesh Anand
  1 AMOI 1ST PRIZE  Debate on Can Triple therapy be made SOC in mCSPC  September 2022
  2 AMOI 3RD PRIZE AMOI Quiz JAN 2024
  3 AMOI 3RD PRIZE AMOI Quiz MARCH 2024
  4 RWE POSTER PRESENTATION MULTIPLE MYELOMA IN YOUNG , INSTITUTIONAL EXPERIENCE April,2023
  5 Best of ASCO Oral presentation ADJUVANT OSIMERTINIB IN ADENO CA LUNG MARCH 2024
           
V Dr. Sachet Saxena
  1 RWE ORAL  PRESENTATION BMT INSTITUTIONAL EXPERIENCE April,2023
  2 Best of ASCO Oral presentation PEMBROLIZUMAB IN TKI RESISTANT ADENO CA LUNG MARCH 2024